BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 25499224)

  • 1. A novel RNA in situ hybridization assay for the long noncoding RNA SChLAP1 predicts poor clinical outcome after radical prostatectomy in clinically localized prostate cancer.
    Mehra R; Shi Y; Udager AM; Prensner JR; Sahu A; Iyer MK; Siddiqui J; Cao X; Wei J; Jiang H; Feng FY; Chinnaiyan AM
    Neoplasia; 2014 Dec; 16(12):1121-7. PubMed ID: 25499224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of the Long Non-coding RNA SChLAP1 Independently Predicts Lethal Prostate Cancer.
    Mehra R; Udager AM; Ahearn TU; Cao X; Feng FY; Loda M; Petimar JS; Kantoff P; Mucci LA; Chinnaiyan AM
    Eur Urol; 2016 Oct; 70(4):549-552. PubMed ID: 26724257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RNA biomarkers associated with metastatic progression in prostate cancer: a multi-institutional high-throughput analysis of SChLAP1.
    Prensner JR; Zhao S; Erho N; Schipper M; Iyer MK; Dhanasekaran SM; Magi-Galluzzi C; Mehra R; Sahu A; Siddiqui J; Davicioni E; Den RB; Dicker AP; Karnes RJ; Wei JT; Klein EA; Jenkins RB; Chinnaiyan AM; Feng FY
    Lancet Oncol; 2014 Dec; 15(13):1469-1480. PubMed ID: 25456366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Prostate Cancer "Nimbosus": Genomic Instability and SChLAP1 Dysregulation Underpin Aggression of Intraductal and Cribriform Subpathologies.
    Chua MLK; Lo W; Pintilie M; Murgic J; Lalonde E; Bhandari V; Mahamud O; Gopalan A; Kweldam CF; van Leenders GJLH; Verhoef EI; Hoogland AM; Livingstone J; Berlin A; Dal Pra A; Meng A; Zhang J; Orain M; Picard V; Hovington H; Bergeron A; Lacombe L; Fradet Y; Têtu B; Reuter VE; Fleshner N; Fraser M; Boutros PC; van der Kwast TH; Bristow RG
    Eur Urol; 2017 Nov; 72(5):665-674. PubMed ID: 28511883
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical prospects of long noncoding RNAs as novel biomarkers and therapeutic targets in prostate cancer.
    Mouraviev V; Lee B; Patel V; Albala D; Johansen TE; Partin A; Ross A; Perera RJ
    Prostate Cancer Prostatic Dis; 2016 Mar; 19(1):14-20. PubMed ID: 26503110
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multi-institutional Analysis Shows that Low PCAT-14 Expression Associates with Poor Outcomes in Prostate Cancer.
    White NM; Zhao SG; Zhang J; Rozycki EB; Dang HX; McFadden SD; Eteleeb AM; Alshalalfa M; Vergara IA; Erho N; Arbeit JM; Karnes RJ; Den RB; Davicioni E; Maher CA
    Eur Urol; 2017 Feb; 71(2):257-266. PubMed ID: 27460352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High expression of SCHLAP1 in primary prostate cancer is an independent predictor of biochemical recurrence, despite substantial heterogeneity.
    Kidd SG; Carm KT; Bogaard M; Olsen LG; Bakken AC; Løvf M; Lothe RA; Axcrona K; Axcrona U; Skotheim RI
    Neoplasia; 2021 Jun; 23(6):634-641. PubMed ID: 34107378
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification and Validation of PCAT14 as Prognostic Biomarker in Prostate Cancer.
    Shukla S; Zhang X; Niknafs YS; Xiao L; Mehra R; Cieślik M; Ross A; Schaeffer E; Malik B; Guo S; Freier SM; Bui HH; Siddiqui J; Jing X; Cao X; Dhanasekaran SM; Feng FY; Chinnaiyan AM; Malik R
    Neoplasia; 2016 Aug; 18(8):489-99. PubMed ID: 27566105
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long Noncoding RNA SChLAP1 Accelerates the Proliferation and Metastasis of Prostate Cancer via Targeting miR-198 and Promoting the MAPK1 Pathway.
    Li Y; Luo H; Xiao N; Duan J; Wang Z; Wang S
    Oncol Res; 2018 Jan; 26(1):131-143. PubMed ID: 28492138
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long Noncoding RNA
    Ji J; Xu R; Ding K; Bao G; Zhang X; Huang B; Wang X; Martinez A; Wang X; Li G; Miletic H; Thorsen F; Bjerkvig R; Xiang L; Han B; Chen A; Li X; Wang J
    Clin Cancer Res; 2019 Nov; 25(22):6868-6881. PubMed ID: 31492748
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel long non-coding RNAs are specific diagnostic and prognostic markers for prostate cancer.
    Böttcher R; Hoogland AM; Dits N; Verhoef EI; Kweldam C; Waranecki P; Bangma CH; van Leenders GJ; Jenster G
    Oncotarget; 2015 Feb; 6(6):4036-50. PubMed ID: 25686826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor-Derived Exosomal Long Noncoding RNAs as Promising Diagnostic Biomarkers for Prostate Cancer.
    Wang YH; Ji J; Wang BC; Chen H; Yang ZH; Wang K; Luo CL; Zhang WW; Wang FB; Zhang XL
    Cell Physiol Biochem; 2018; 46(2):532-545. PubMed ID: 29614511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibiting malignant phenotypes of the bladder cancer cells by silencing long noncoding RNA SChLAP1.
    Zhang J; Shi Z; Nan Y; Li M
    Int Urol Nephrol; 2016 May; 48(5):711-6. PubMed ID: 26861061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current Insights into Long Non-Coding RNAs (LncRNAs) in Prostate Cancer.
    Smolle MA; Bauernhofer T; Pummer K; Calin GA; Pichler M
    Int J Mol Sci; 2017 Feb; 18(2):. PubMed ID: 28241429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long noncoding RNAs in prostate cancer: overview and clinical implications.
    Malik B; Feng FY
    Asian J Androl; 2016; 18(4):568-74. PubMed ID: 27072044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long noncoding RNA in prostate, bladder, and kidney cancer.
    Martens-Uzunova ES; Böttcher R; Croce CM; Jenster G; Visakorpi T; Calin GA
    Eur Urol; 2014 Jun; 65(6):1140-51. PubMed ID: 24373479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The long noncoding RNA SChLAP1 promotes aggressive prostate cancer and antagonizes the SWI/SNF complex.
    Prensner JR; Iyer MK; Sahu A; Asangani IA; Cao Q; Patel L; Vergara IA; Davicioni E; Erho N; Ghadessi M; Jenkins RB; Triche TJ; Malik R; Bedenis R; McGregor N; Ma T; Chen W; Han S; Jing X; Cao X; Wang X; Chandler B; Yan W; Siddiqui J; Kunju LP; Dhanasekaran SM; Pienta KJ; Feng FY; Chinnaiyan AM
    Nat Genet; 2013 Nov; 45(11):1392-8. PubMed ID: 24076601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complete androgen ablation suppresses prostate stem cell antigen (PSCA) mRNA expression in human prostate carcinoma.
    Zhigang Z; Wenlu S
    Prostate; 2005 Dec; 65(4):299-305. PubMed ID: 16015594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long Non-Coding RNA as Potential Biomarker for Prostate Cancer: Is It Making a Difference?
    Deng J; Tang J; Wang G; Zhu YS
    Int J Environ Res Public Health; 2017 Mar; 14(3):. PubMed ID: 28272371
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long non-coding RNA: A newly deciphered "code" in prostate cancer.
    Zhang A; Zhang J; Kaipainen A; Lucas JM; Yang H
    Cancer Lett; 2016 Jun; 375(2):323-330. PubMed ID: 26965999
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.